Blog
1 Growth Stock Near Its 52-Week Low That Could Soar
Pandemic-related dynamics helped catapult some companies to higher levels of success. Fiverr International (NYSE: FVRR), a business that runs an online marketplace for freelancers, was one of them
2 High-Yielding Dividend Stocks Worth the Risk and 1 That Isn't
Healthcare-connected real estate investment trusts (REITs) combine the recession-resistant medical sector with the high-yield dividends that REITs are known for.
That doesn't mean everything has
4 Charts You Need to See Before Buying SNDL
Cannabis company SNDL (NASDAQ: SNDL) is a growth-oriented business that many investors are hoping can generate great returns in the long run. The company's acquisition efforts and diversification
I Like Tesla, but I Dare Not Buy the Stock
Tesla (NASDAQ: TSLA) has been a massive wealth generator for early investors thanks to its leadership in the growing electric vehicle industry.
While a handful of visionary investors benefited
A Bear Market Gift: This Top-Notch Dividend Stock Is Down 38%
The bear market in stocks is causing shares of most companies to decline by more than 20%. Some are down even more. Alexandria Real Estate Equities' (NYSE: ARE) stock price has plummeted roughly 38%
AT&T Fiber Is Firing On All Cylinders? Not So Fast.
Telco giant AT&T (NYSE: T) is finally showing some much-needed signs of life. The company picked up an impressive 708,000 postpaid wireless customers last quarter, and added 338,000 fiber broadband
3 Big-Time Passive Income Stocks to Consider Loading Up On During the Bear Market
Bear markets can be an opportunity for those with cash sitting on the sidelines. With stock prices falling more than 20%, dividend yields are surging. And that means you can earn more passive income
Is Now the Right Time to Buy Nike Stock?
Nike (NYSE: NKE) investors have no shortage of worries heading into the key holiday shopping season. Sales trends are slowing in key markets like China and the U.S., inventory is building, and a
Would Warren Buffett Buy Tilray Brands Stock?
If you're a fan of Warren Buffett's long-term approach to investing, it pays to know what the Oracle of Omaha might think about the stocks of today that you suspect could be the mega-winners of 20
Microsoft Revenue Surges on Cloud Strength. Is the Stock a Buy?
The larger a company grows, the more difficult it is to generate market-beating returns -- at least in theory. Yet, even in the middle of a market downturn, Microsoft (NASDAQ: MSFT) showed why it's
3 Social Security Moves That Could Make or Break Your Retirement
Millions of seniors rely on Social Security to make ends meet in retirement. For many older adults, these monthly checks will be their primary or even sole source of income.
That means it's
This Major Indicator Could Mean Explosive Growth for Lockheed Martin
Stock analysts would probably describe the numbers that Lockheed Martin (NYSE: LMT) reported last week as a "mixed" quarter -- earnings above estimates, but revenue below them, and below consensus
Here Is Why AMD Stock Can Be a Huge Winner in This Market
Today's video focuses on Advanced Micro Devices (NASDAQ: AMD), its various data center solutions, and how it can accelerate its revenue growth. Check out the short video to learn more, consider
Is Nu Holdings Stock a Buy?
No stock remains hidden once Warren Buffett notices it. That's why Nu Holdings (NYSE: NU), a small but growing Brazilian bank stock, has come onto many investors' radars. It has traded for less than
48% of Workers Lack Social Security Knowledge. Here Are 3 Key Things You Need to Know
Social Security pays a monthly benefit to millions of older Americans. And for many seniors, that benefit is their primary or even sole source of income.
Meanwhile, there's a good chance you'll end
Warren Buffett Owns a Lot of Stocks: Here's the One I'm Most Excited About
Berkshire Hathaway (NYSE: BRK.A)(NYSE: BRK.B) owns about 50 stocks in its portfolio, with a combined market value of around $338 billion as of this writing. Many of them -- especially the larger
Income Investors: Last Call to Lock In a Guaranteed 9.62% Yield
Series I Savings Bonds -- informally known as "I bonds" to many Americans -- are an inflation-protected form of savings bonds you can purchase directly from the United States Treasury.
Right now, I
A Hidden Risk for Amazon's Cloud Business
Public cloud platforms like Amazon's (NASDAQ: AMZN) AWS have truly changed the game for start-ups. Instead of having little choice but to own and operate their own servers, the cloud makes it easy
Is This Really the Right Time to Invest in the Stock Market?
The trend line for the S&P 500 index this year has been a rocky downhill path. The index, which includes most of the biggest and strongest public companies in the U.S., is down more than 20% year to
Where Will Lemonade Be in 3 Years?
Three years ago, Lemonade (NYSE: LMND) wasn't even a public company. But since its debut as a market darling in July 2020, its stock has lost 67%.
It has gone through a whirlwind of ups and downs
Apple's Most Important Catalyst Just Got Better
While Apple's (NASDAQ: AAPL) iPhone sales are often the most closely watched item when the company reports earnings, it's the tech giant's steadily growing services business that's arguably most
2 Buffett Stocks to Buy More Of In October
Billionaire investor Warren Buffett doesn't focus on the short term when he buys a stock. Instead, he looks at what that company may bring to his portfolio over time. That's a great investment
3 Beaten-Down Growth Stocks to Buy Right Now
The bear market may have already hit its ultimate bottom. Or, maybe it hasn't -- we just don't know. What we do know is, a bunch of otherwise great growth stocks are much cheaper right now than they
Are Pfizer and Moderna Stocks Buys With a Potential COVID Surge Coming?
COVID-19 hasn't gone away. But a quick look at the charts of Pfizer (NYSE: PFE) and Moderna (NASDAQ: MRNA) stocks will tell you that the coronavirus isn't as big of a concern as it used to be.
The
Is Biogen a Buy After It Boosted Guidance?
The good news keeps coming in for Biogen (NASDAQ: BIIB). On Tuesday, the drugmaker reported its third-quarter results, and for the first time in a while, investors found something in one of its


